The programmed-cell death protein 1 (PD-1) immune checkpoint has been shown to be expressed on both circulating and tumor-infiltrating NK cells across several cancer types (110–115), being correlated with poor patient prognosis (116). Here, PDCD1 is linked to neoplasm.